<i>ERBB2</i>-Mutant Gastrointestinal Tumors Represent Heterogeneous Molecular Biology, Particularly in Microsatellite Instability, Tumor Mutation Burden, and Co-Mutated Genes: An In Silico Study
During recent years, activating mutations in <i>ERBB2</i> have been reported in solid tumors of various organs, and clinical trials targeting <i>ERBB2</i>-mutant tumors have been conducted. However, no effective treatment has been established for gastrointestinal tumors targe...
Main Authors: | Shiro Uchida, Takashi Sugino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/9/468 |
Similar Items
-
ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype
by: Melica Nourmoussavi Brodeur, et al.
Published: (2024-10-01) -
Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma
by: Alexander Quaas, et al.
Published: (2019-02-01) -
Targeting ERBB2 mutations in solid tumors: biological and clinical implications
by: Sophie Cousin, et al.
Published: (2018-06-01) -
Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer
by: Xue‐Wu Wei, et al.
Published: (2020-06-01) -
An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway
by: Zi-Yan Yang, et al.
Published: (2020-01-01)